KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Johnson & Johnson (JNJ) Shares Outstanding (Diluted Average) (2016 - 2026)

Johnson & Johnson's Shares Outstanding (Diluted Average) history spans 18 years, with the latest figure at $2.4 billion for Q1 2026.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 0.88% to $2.4 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $2.4 billion, a 0.88% increase, with the full-year FY2025 number at $2.4 billion, changed 0.0% from a year prior.
  • Shares Outstanding (Diluted Average) hit $2.4 billion in Q1 2026 for Johnson & Johnson, up from $2.4 billion in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for JNJ hit a ceiling of $2.7 billion in Q1 2022 and a floor of $2.4 billion in Q2 2025.
  • Historically, Shares Outstanding (Diluted Average) has averaged $2.5 billion across 5 years, with a median of $2.5 billion in 2023.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): dropped 7.69% in 2024 and later rose 0.88% in 2026.
  • Tracing JNJ's Shares Outstanding (Diluted Average) over 5 years: stood at $2.7 billion in 2022, then fell by 3.79% to $2.6 billion in 2023, then decreased by 5.12% to $2.4 billion in 2024, then changed by 0.0% to $2.4 billion in 2025, then increased by 0.65% to $2.4 billion in 2026.
  • Business Quant data shows Shares Outstanding (Diluted Average) for JNJ at $2.4 billion in Q1 2026, $2.4 billion in Q4 2025, and $2.4 billion in Q3 2025.